<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Shi</surname>
   <given-names>ST</given-names>
  </name>
  <name>
   <surname>Herlihy</surname>
   <given-names>KJ</given-names>
  </name>
  <name>
   <surname>Graham</surname>
   <given-names>JP</given-names>
  </name>
  <name>
   <surname>Nonomiya</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Rahavendran</surname>
   <given-names>SV</given-names>
  </name>
  <name>
   <surname>Skor</surname>
   <given-names>H</given-names>
  </name>
  <name>
   <surname>Irvine</surname>
   <given-names>R</given-names>
  </name>
  <name>
   <surname>Binford</surname>
   <given-names>S</given-names>
  </name>
  <name>
   <surname>Tatlock</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Li</surname>
   <given-names>H</given-names>
  </name>
  <article-title>Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2009</year>
  <volume>53</volume>
  <fpage>2544</fpage>
  <lpage>2552</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.01599-08</pub-id>
  <pub-id pub-id-type="pmid">19307358</pub-id>
 </mixed-citation>
</ref>
